The anti-proliferative and anti-androgenic activity of different pomegranate accessions

This study monitored the anti-proliferative activity of pomegranate (Punica granatum L.) peel homogenates against breast (MCF7 and MDA-MB-453) and prostate (LNCaP and PC-3) cancer cell lines using 29 different accessions to study the natural diversity in these accessions. Using MTT method, it was re...

Full description

Bibliographic Details
Main Authors: Ola Orgil, Limor Spector, Doron Holland, Jamal Mahajna, Rachel Amir
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464616302389
_version_ 1831584710373933056
author Ola Orgil
Limor Spector
Doron Holland
Jamal Mahajna
Rachel Amir
author_facet Ola Orgil
Limor Spector
Doron Holland
Jamal Mahajna
Rachel Amir
author_sort Ola Orgil
collection DOAJ
description This study monitored the anti-proliferative activity of pomegranate (Punica granatum L.) peel homogenates against breast (MCF7 and MDA-MB-453) and prostate (LNCaP and PC-3) cancer cell lines using 29 different accessions to study the natural diversity in these accessions. Using MTT method, it was revealed that high anti-proliferative activity was observed against MCF7, MDA-MB-453 and LNCaP (androgen-dependent) cell lines for most accessions, while the androgen-independent prostate cancer cell line, PC-3, exhibited relatively high resistance. Peel extracts displayed the highest LNCaP inhibition activity compared to aril juice and seed homogenates. Eight accessions exhibiting the highest anti-proliferative activity were studied further using the LNCaP and PC-3 cancer cells. IC50 and clonogenicity inhibition were determined. Several accessions were found to inhibit androgen receptor activity but not NF-κB transcription function. This study illustrated the importance of exploiting natural pomegranate variation to identify accessions exhibiting potential selective activity for the treatment of specific types of cancer.
first_indexed 2024-12-17T21:04:09Z
format Article
id doaj.art-31bae075a2564ef688ec696b8b77c5a5
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-17T21:04:09Z
publishDate 2016-10-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-31bae075a2564ef688ec696b8b77c5a52022-12-21T21:32:38ZengElsevierJournal of Functional Foods1756-46462016-10-0126517528The anti-proliferative and anti-androgenic activity of different pomegranate accessionsOla Orgil0Limor Spector1Doron Holland2Jamal Mahajna3Rachel Amir4Migal Galilee Technology Center, P.O. Box 831, Kiryat Shmona 11016, Israel; Tel Hai College, Upper Galilee, IsraelMigal Galilee Technology Center, P.O. Box 831, Kiryat Shmona 11016, IsraelInstitute of Plant Sciences, Agricultural Research Organization, Newe Ya'ar Research Center, Ramat Yishay 30095, IsraelMigal Galilee Technology Center, P.O. Box 831, Kiryat Shmona 11016, Israel; Tel Hai College, Upper Galilee, IsraelMigal Galilee Technology Center, P.O. Box 831, Kiryat Shmona 11016, Israel; Tel Hai College, Upper Galilee, Israel; Corresponding author. Laboratory of Plant Science, Migal Galilee Technology Center, P.O. Box 831, Kiryat Shmona 11016, Israel. Fax: +972 4 6944980.This study monitored the anti-proliferative activity of pomegranate (Punica granatum L.) peel homogenates against breast (MCF7 and MDA-MB-453) and prostate (LNCaP and PC-3) cancer cell lines using 29 different accessions to study the natural diversity in these accessions. Using MTT method, it was revealed that high anti-proliferative activity was observed against MCF7, MDA-MB-453 and LNCaP (androgen-dependent) cell lines for most accessions, while the androgen-independent prostate cancer cell line, PC-3, exhibited relatively high resistance. Peel extracts displayed the highest LNCaP inhibition activity compared to aril juice and seed homogenates. Eight accessions exhibiting the highest anti-proliferative activity were studied further using the LNCaP and PC-3 cancer cells. IC50 and clonogenicity inhibition were determined. Several accessions were found to inhibit androgen receptor activity but not NF-κB transcription function. This study illustrated the importance of exploiting natural pomegranate variation to identify accessions exhibiting potential selective activity for the treatment of specific types of cancer.http://www.sciencedirect.com/science/article/pii/S1756464616302389Androgen receptorAnti-proliferative activityCancer cell linesDifferent accessionsPhenolic compoundsPomegranate
spellingShingle Ola Orgil
Limor Spector
Doron Holland
Jamal Mahajna
Rachel Amir
The anti-proliferative and anti-androgenic activity of different pomegranate accessions
Journal of Functional Foods
Androgen receptor
Anti-proliferative activity
Cancer cell lines
Different accessions
Phenolic compounds
Pomegranate
title The anti-proliferative and anti-androgenic activity of different pomegranate accessions
title_full The anti-proliferative and anti-androgenic activity of different pomegranate accessions
title_fullStr The anti-proliferative and anti-androgenic activity of different pomegranate accessions
title_full_unstemmed The anti-proliferative and anti-androgenic activity of different pomegranate accessions
title_short The anti-proliferative and anti-androgenic activity of different pomegranate accessions
title_sort anti proliferative and anti androgenic activity of different pomegranate accessions
topic Androgen receptor
Anti-proliferative activity
Cancer cell lines
Different accessions
Phenolic compounds
Pomegranate
url http://www.sciencedirect.com/science/article/pii/S1756464616302389
work_keys_str_mv AT olaorgil theantiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT limorspector theantiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT doronholland theantiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT jamalmahajna theantiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT rachelamir theantiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT olaorgil antiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT limorspector antiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT doronholland antiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT jamalmahajna antiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions
AT rachelamir antiproliferativeandantiandrogenicactivityofdifferentpomegranateaccessions